Header Logo

Connection

Patrick McCann to CTLA-4 Antigen

Back to Details
This is a "connection" page, showing publications Patrick McCann has written about CTLA-4 Antigen.
Patrick McCann
Connection Strength
0.245
CTLA-4 Antigen
  1. Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial. Cell Rep Med. 2026 Mar 17; 7(3):102638.
    View in: PubMed
    Score: 0.245
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.